Intravenous immunoglobulin treatment in autoimmune neurological disorders: pilot study on early effects on patients' quality of life.
D000293:Adolescent; D000328:Adult; D000368:Aged; D020274:Autoimmune Diseases of the Nervous System / Q000188:drug therapy*; D019317:Evidence-Based Medicine; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects; D011788:Quality of Life / Q000523:psychology; D020127:Recovery of Function; D011795:Surveys and Questionnaires; D016896:Treatment Outcome
D016756:Immunoglobulins, Intravenous